SPOTLIGHT: St. Jude gets OK for radio-frequency heart implants

St. Jude Medical got the FDA's OK for its first wireless devices to treat patients with heart failure and irregular heartbeat. The devices allow programmers to use radio frequency technology to reformat settings, and they include patient-management tools that can monitor patients' exercise.ᅠReport

Suggested Articles

The FDA has found a handful of issues with Biocon’s small molecule API facility in Bengaluru, India.

Pfizer plans to sell two assets to its Mylan-Upjohn spinoff, adding $598 million in revenues—but that won't do much for its profits, analysts warned.

AstraZeneca has made a hefty investment in Brilinta with billions in R&D costs. But will that sunk cost ever turn a profit for the British drugmaker?